应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRVS Corvus Pharmaceuticals, Inc.
未开盘 04-22 16:00:00 EDT
3.33
+0.11
+3.42%
盘后
3.16
-0.17
-4.98%
19:05 EDT
最高
3.35
最低
3.20
成交量
128.92万
今开
3.28
昨收
3.22
日振幅
4.66%
总市值
2.27亿
流通市值
1.74亿
总股本
6,814万
成交额
423.06万
换手率
2.47%
流通股本
5,215万
市净率
6.97
ROE
-174.85%
每股收益
-1.02
52周最高
10.00
52周最低
1.39
市盈率
-3.26
股息
0.00
股息收益率
0.00
ROA
-30.08%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%
市场透视 · 03-10
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%
Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.33%
市场透视 · 03-06
Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.33%
Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%
市场透视 · 02-27
Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%
Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.52%报4.16美元
市场透视 · 02-26
Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.52%报4.16美元
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.13%
市场透视 · 02-25
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.13%
Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.22%报4.18美元
市场透视 · 02-21
Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.22%报4.18美元
Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.14%报4.53美元
市场透视 · 02-19
Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.14%报4.53美元
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.06%报5.61美元
市场透视 · 02-05
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.06%报5.61美元
Corvus Pharmaceuticals, Inc.盘中异动 急速拉升5.13%
市场透视 · 02-04
Corvus Pharmaceuticals, Inc.盘中异动 急速拉升5.13%
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.22%
市场透视 · 02-03
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.22%
Corvus Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.71%
市场透视 · 01-30
Corvus Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.71%
Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.11%
市场透视 · 01-27
Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.11%
Corvus Pharmaceuticals, Inc.盘中异动 快速跳水5.15%
市场透视 · 01-23
Corvus Pharmaceuticals, Inc.盘中异动 快速跳水5.15%
Corvus Pharmaceuticals, Inc.盘中异动 急速上涨5.17%报5.49美元
市场透视 · 01-22
Corvus Pharmaceuticals, Inc.盘中异动 急速上涨5.17%报5.49美元
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.92%
市场透视 · 01-17
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.92%
Corvus Pharmaceuticals, Inc.盘中异动 急速下挫5.13%报5.36美元
市场透视 · 01-10
Corvus Pharmaceuticals, Inc.盘中异动 急速下挫5.13%报5.36美元
Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.32%
市场透视 · 01-06
Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.32%
Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.34%报5.72美元
市场透视 · 01-03
Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.34%报5.72美元
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.18%报4.94美元
市场透视 · 2024-12-30
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.18%报4.94美元
Corvus Pharmaceuticals, Inc.盘中异动 快速上涨5.10%
市场透视 · 2024-12-26
Corvus Pharmaceuticals, Inc.盘中异动 快速上涨5.10%
加载更多
公司概况
公司名称:
Corvus Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
2016-03-23
主营业务:
Corvus Pharmaceuticals, Inc.于2014年1月27日在特拉华州注册成立,并于2014年11月开始运作。该公司是一家临床阶段的生物制药公司,专注于发展和商业化那些旨在利用免疫系统攻击癌细胞的新免疫治疗肿瘤方案。自从2014年11月开始运营起,已建成四个免疫肿瘤的方案,其中三个重点腺苷癌症轴调节免疫反应的管道。该公司的主导候选产品,CPI-444,A2A受体腺苷,免疫检查点的口服小分子拮抗剂。
发行价格:
15.00
{"stockData":{"symbol":"CRVS","market":"US","secType":"STK","nameCN":"Corvus Pharmaceuticals, Inc.","latestPrice":3.33,"timestamp":1745352000000,"preClose":3.22,"halted":0,"volume":1289217,"hourTrading":{"tag":"盘后","latestPrice":3.1642,"preClose":3.33,"latestTime":"19:05 EDT","volume":41498,"amount":138183.24,"timestamp":1745363156765},"delay":0,"floatShares":52153080,"shares":68135796,"eps":-1.021445,"marketStatus":"未开盘","change":0.11,"latestTime":"04-22 16:00:00 EDT","open":3.28,"high":3.3499,"low":3.2,"amount":4230637.781652,"amplitude":0.046553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.021445,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1458705600000,"exchange":"NASDAQ","adjPreClose":3.22,"preHourTrading":{"tag":"盘前","latestPrice":3.3,"preClose":3.22,"latestTime":"09:25 EDT","volume":1,"amount":3.3,"timestamp":1745328306303},"postHourTrading":{"tag":"盘后","latestPrice":3.1642,"preClose":3.33,"latestTime":"19:05 EDT","volume":41498,"amount":138183.24,"timestamp":1745363156765},"volumeRatio":1.313476,"impliedVol":2.1581,"impliedVolPercentile":0.828},"requestUrl":"/m/hq/s/CRVS","defaultTab":"news","newsList":[{"id":"2518272633","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272633?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615414,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分,Corvus Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.19%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大,Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为672.40%、342.08%、93.86%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Pmgc Holdings Inc.,振幅分别为41.36%、40.24%、32.14%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220335a26a3104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220335a26a3104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2517164364","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164364?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:40","pubTimestamp":1741275643,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时40分,Corvus Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.33%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。其相关个股中,Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Plus Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Aditxt, Inc.较为活跃,换手率分别为2212.44%、1590.75%、85.87%,振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为68.33%、67.37%、49.27%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234043963c5ac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234043963c5ac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2514433086","title":"Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514433086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514433086?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:57","pubTimestamp":1740689829,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时57分,Corvus Pharmaceuticals, Inc.股票出现异动,股价急速下跌5.06%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1955.27%、424.52%、198.31%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2514862265","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.52%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862265?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:28","pubTimestamp":1740601714,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时28分,Corvus Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.52%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.69%。其相关个股中,Enveric Biosciences, Inc.、Renovaro Inc.、Salarius Pharmaceuticals, Inc.涨幅较大,Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃,换手率分别为6844.95%、332.32%、265.02%,振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为194.07%、81.11%、70.39%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270428359893eace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270428359893eace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2514013012","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013012?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:18","pubTimestamp":1740496685,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时18分,Corvus Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.13%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。其相关个股中,Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1050.65%、845.70%、586.00%,振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp,振幅分别为121.95%、63.66%、61.16%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231805abdc89ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231805abdc89ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2513216438","title":"Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.22%报4.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513216438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513216438?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:42","pubTimestamp":1740163342,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时42分,Corvus Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.22%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Osr Holdings, Inc.、Invivyd, Inc.涨幅较大,Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为285.22%、247.28%、136.38%,振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为76.52%、70.25%、61.26%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024222abd7e3aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024222abd7e3aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2512431742","title":"Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.14%报4.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512431742?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:54","pubTimestamp":1739998480,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时54分,Corvus Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.14%。截至发稿,该股报4.53美元/股,成交量41.9916万股,换手率0.65%,振幅4.82%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220045440abd5422b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220045440abd5422b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2509287189","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.06%报5.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509287189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509287189?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:44","pubTimestamp":1738766660,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时44分,Corvus Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.06%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.61%。其相关个股中,Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3412.32%、954.18%、645.74%,振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Oragenics Inc.、Pasithea Therapeutics Corp.,振幅分别为54.05%、48.82%、35.10%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205224420987b7e0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205224420987b7e0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2508450219","title":"Corvus Pharmaceuticals, Inc.盘中异动 急速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508450219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508450219?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:59","pubTimestamp":1738681177,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时59分,Corvus Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.13%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.71%。其相关个股中,Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大,Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃,换手率分别为1342.76%、833.11%、211.56%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025,振幅分别为49.88%、49.48%、40.00%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225937abc22d97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225937abc22d97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2508234551","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508234551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508234551?lang=zh_cn&edition=full","pubTime":"2025-02-04 00:58","pubTimestamp":1738601930,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日00时58分,Corvus Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.22%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为637.75%、451.14%、392.91%,振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.,振幅分别为170.13%、75.23%、63.94%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204005850abc125b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204005850abc125b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2507743671","title":"Corvus Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507743671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507743671?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:40","pubTimestamp":1738262422,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日02时40分,Corvus Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.71%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Nutriband Inc C/Wts 涨幅较大,Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃,换手率分别为1770.77%、288.86%、236.37%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited,振幅分别为65.98%、63.82%、61.86%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131024023a2347e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131024023a2347e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2506358148","title":"Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506358148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506358148?lang=zh_cn&edition=full","pubTime":"2025-01-28 03:50","pubTimestamp":1738007451,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日03时50分,Corvus Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.11%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。其相关个股中,Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、Sellas Life Sciences Group, Inc.涨幅较大,Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为2179.70%、1059.97%、268.17%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为108.60%、99.77%、65.16%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012803505296126797&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012803505296126797&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2505300046","title":"Corvus Pharmaceuticals, Inc.盘中异动 快速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505300046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505300046?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:02","pubTimestamp":1737651751,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时02分,Corvus Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.15%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.54%。其相关个股中,Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为3663.99%、2927.92%、671.70%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.,振幅分别为246.43%、65.78%、55.57%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124010231abb619a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124010231abb619a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2505724660","title":"Corvus Pharmaceuticals, Inc.盘中异动 急速上涨5.17%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505724660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505724660?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:23","pubTimestamp":1737559395,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时23分,Corvus Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.17%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Immunoprecise Antibodies Ltd.、Nutriband Inc C/Wts 、Dermata Therapeutics Inc C/Wts 涨幅较大,Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为795.09%、150.50%、67.86%,振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Nutriband Inc C/Wts 、Immatics N V C/Wts 01/07/2025 ,振幅分别为47.48%、43.41%、41.27%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122232316abb4b176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122232316abb4b176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2504675071","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504675071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504675071?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:06","pubTimestamp":1737126408,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时06分,Corvus Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.92%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230648986a1e6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230648986a1e6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2502604818","title":"Corvus Pharmaceuticals, Inc.盘中异动 急速下挫5.13%报5.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502604818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502604818?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:03","pubTimestamp":1736521437,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时03分,Corvus Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.13%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.06%。其相关个股中,Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大,Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃,换手率分别为1089.24%、314.58%、193.47%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.,振幅分别为72.56%、41.78%、37.29%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035795ff758d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035795ff758d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2501258789","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501258789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501258789?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:51","pubTimestamp":1736175115,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时51分,Corvus Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.32%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Cytomed Therapeutics Limited较为活跃,换手率分别为590.90%、254.30%、84.88%,振幅较大的相关个股有Scisparc Ltd.、Sonnet Biotherapeutics Holdings, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为81.44%、44.00%、39.34%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106225155a2179b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106225155a2179b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2500110540","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.34%报5.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500110540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500110540?lang=zh_cn&edition=full","pubTime":"2025-01-03 23:15","pubTimestamp":1735917355,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日23时15分,Corvus Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.34%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Cyclacel Pharmaceuticals, Inc.涨幅较大,Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为1523.72%、1151.66%、290.15%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.,振幅分别为143.91%、101.10%、87.11%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103231556ab9d6497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103231556ab9d6497&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2495248165","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.18%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495248165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495248165?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:18","pubTimestamp":1735571884,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时18分,Corvus Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.18%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.21%。其相关个股中,Vincerx Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nls Pharmaceutics Ltd.涨幅较大,Nls Pharmaceutics Ltd.、Vincerx Pharma, Inc.、Polyrizon Ltd.较为活跃,换手率分别为754.14%、502.45%、362.08%,振幅较大的相关个股有Vincerx Pharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为120.05%、52.75%、52.63%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023180595f2ce3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023180595f2ce3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2494786697","title":"Corvus Pharmaceuticals, Inc.盘中异动 快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494786697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494786697?lang=zh_cn&edition=full","pubTime":"2024-12-26 22:44","pubTimestamp":1735224285,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日22时44分,Corvus Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.10%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为1422.86%、248.84%、102.99%,振幅较大的相关个股有Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ,振幅分别为134.99%、58.66%、41.41%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122622444595ede3d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122622444595ede3d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corvusbiotech.com","stockEarnings":[{"period":"1week","weight":0.0278},{"period":"1month","weight":-0.2274},{"period":"3month","weight":-0.3879},{"period":"6month","weight":-0.5664},{"period":"1year","weight":1.3125},{"period":"ytd","weight":-0.3776}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corvus Pharmaceuticals, Inc.于2014年1月27日在特拉华州注册成立,并于2014年11月开始运作。该公司是一家临床阶段的生物制药公司,专注于发展和商业化那些旨在利用免疫系统攻击癌细胞的新免疫治疗肿瘤方案。自从2014年11月开始运营起,已建成四个免疫肿瘤的方案,其中三个重点腺苷癌症轴调节免疫反应的管道。该公司的主导候选产品,CPI-444,A2A受体腺苷,免疫检查点的口服小分子拮抗剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.022575},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.054432},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.007101},{"month":4,"riseRate":0.4,"avgChangeRate":-0.082213},{"month":5,"riseRate":0.666667,"avgChangeRate":0.319834},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.075817},{"month":7,"riseRate":0.444444,"avgChangeRate":0.055809},{"month":8,"riseRate":0.666667,"avgChangeRate":0.121396},{"month":9,"riseRate":0.444444,"avgChangeRate":0.086364},{"month":10,"riseRate":0.333333,"avgChangeRate":0.009486},{"month":11,"riseRate":0.555556,"avgChangeRate":-0.010791},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.055784}],"exchange":"NASDAQ","name":"Corvus Pharmaceuticals, Inc.","nameEN":"Corvus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corvus Pharmaceuticals, Inc.,CRVS,Corvus Pharmaceuticals, Inc.股票,Corvus Pharmaceuticals, Inc.股票老虎,Corvus Pharmaceuticals, Inc.股票老虎国际,Corvus Pharmaceuticals, Inc.行情,Corvus Pharmaceuticals, Inc.股票行情,Corvus Pharmaceuticals, Inc.股价,Corvus Pharmaceuticals, Inc.股市,Corvus Pharmaceuticals, Inc.股票价格,Corvus Pharmaceuticals, Inc.股票交易,Corvus Pharmaceuticals, Inc.股票购买,Corvus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}